Browse 1 active roles at Ardelyx, Inc.. Filter by category, skill, type, and more.
1 jobs found
No matching roles right now. Try clearing some filters.
Ardelyx, Inc., founded 2007, is a 480 Public Company in the Biotechnology Research industry headquartered in Waltham, MA 02451, US.
Ardelyx, Inc. is a commercial-stage biopharmaceutical company headquartered in Waltham, Massachusetts, dedicated to the development and commercialization of innovative medicines addressing significant unmet medical needs. Operating within the biotechnology research sector, the organization has successfully launched two commercial products approved in the United States: IBSRELA for irritable bowel syndrome with constipation and XPHOZAH for chronic kidney disease patients on dialysis. The company maintains an active pipeline, including Phase 3 development of tenapanor for chronic idiopathic constipation and RDX10531, a next-generation NHE3 inhibitor with potential applications across multiple therapeutic areas.
Ardelyx has established a global footprint through strategic agreements for the development and commercialization of tenapanor outside the United States. In Japan, Kyowa Kirin commercializes the drug as PHOZEVEL for hyperphosphatemia, while a New Drug Application for the same indication has been approved in China with Fosun Pharma. Additionally, Knight Therapeutics manages the commercialization of IBSRELA in the Canadian market. These partnerships extend the company's reach, ensuring patient access to its therapies in diverse international regions while the organization continues to advance its internal research and development initiatives.
See more: Ardelyx, Inc. company profile, Browse all companies.